查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲蛋白质表现市场：按应用、按最终用户、按产品、按表达系统、按国家 - 分析和预测 (2023-2033)
市场调查报告书
商品编码
1532307

欧洲蛋白质表现市场：按应用、按最终用户、按产品、按表达系统、按国家 - 分析和预测 (2023-2033)

Europe Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 75 Pages | 商品交期: 1-5个工作天内

价格

2023 年欧洲蛋白质表现市场规模为 6.372 亿美元。

预计2023年至2033年该市场将以10.48%的复合年增长率成长，2033年达到17.268亿美元。蛋白质表现是指活细胞或生物体内蛋白质的产生或产生。蛋白质的合成、修饰和调节是由 DNA 编码的遗传讯息指导的。这些蛋白质具有复杂多样的结构和功能，对于维持生命和促进各种生物过程至关重要。

主要市场统计数据
预测期 2023-2033
2023年评估 6.372 亿美元
2033 年预测 17.268 亿美元
复合年增长率 10.48%

在生物技术的进步以及研究、治疗和工业应用对重组蛋白的需求不断增长的推动下，欧洲蛋白表达市场正在迅速扩张。蛋白质表现使细胞能够合成、折迭和组装蛋白质，对于阐明生物功能和开发新药至关重要。慢性病的增加增加了对新型生物製药的需求。此外，学术和製药领域研究活动的扩大也推动了市场的成长。

无细胞蛋白质表现系统和改进的表达载体等技术创新正在提高蛋白质生产效率和产量，进一步推动市场成长。欧洲强大的法规结构和对高品质生物产品的关注正在推动蛋白质表现技术的开发和商业化。市场主要企业正在投资研发，推出先进的产品和服务，以满足医疗保健和生物技术产业的多样化需求。

此外，学术机构、研究机构和生物技术公司之间的合作正在促进创新并加速将研究成果转化为临床应用。由于对个人化医疗的日益关注以及蛋白质在诊断和治疗中的使用不断增加，欧洲蛋白质表现市场预计在未来几年将显着成长。

该报告考察了欧洲蛋白质表现市场，并提供了市场概况，包括按应用、最终用户、产品、表达系统和国家分類的趋势，以及进入市场的公司概况。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 供应链概览
  • 监管状况
  • 全球重大事件的影响分析 - COVID-19
  • 市场进入障碍与机会
  • 市场动态概览

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 欧洲

第三章市场－竞争基准化分析与公司概况

  • 企业评价
  • 市场生态系统和主要参与企业
    • Jena Bioscience
    • Lonza Bioscience
    • Merck KGaA
    • Oxford Expression Technologies Ltd
    • QIAGEN NV

第四章调查方法

Product Code: BHL2216SS

Introduction to Europe Protein Expression Market

The Europe protein expression market was valued at $637.2 million in 2023 and is expected to reach $1,726.8 million by 2033, growing at a CAGR of 10.48% between 2023 and 2033. Protein expression refers to the generation or production of proteins within living cells or organisms. Protein synthesis, modification, and regulation are guided by the genetic information encoded in DNA. These proteins have complex and diverse structures and functions that are essential for sustaining life and facilitating various biological processes.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$637.2 Million
2033 Forecast$1,726.8 Million
CAGR10.48%

Market Introduction

The Europe Protein Expression Market is expanding rapidly, propelled by advances in biotechnology and rising demand for recombinant proteins in research, therapeutics, and industrial applications. Protein expression, which involves cells synthesizing, folding, and assembling proteins, is critical for understanding biological functions and developing new drugs. The increasing prevalence of chronic diseases is driving demand for novel biopharmaceuticals. Furthermore, the expansion of research activities in the academic and pharmaceutical sectors promotes market growth.

Technological innovations, such as cell-free protein expression systems and improved expression vectors, improve protein production efficiency and yield, driving market growth even further. Europe's strong regulatory framework and emphasis on high-quality bioproducts encourage the development and commercialization of protein expression technologies. Key market players are investing in R&D to launch advanced products and services that meet the diverse needs of the healthcare and biotech industries.

Furthermore, collaborations among academic institutions, research organizations, and biotechnology companies promote innovation and speed up the translation of research findings into clinical applications. With a growing emphasis on personalized medicine and the increased use of proteins in diagnostics and therapeutics, the Europe Protein Expression Market is expected to grow significantly in the coming years.

Market Segmentation

Segmentation 1: by Application

  • Biopharmaceutical Manufacturing
  • Research and Development
  • Industrial Usage

Segmentation 2: by End User

  • Biopharmaceutical and Biotech Companies
  • CRO and CDMO
  • Academia
  • Other End Users

Segmentation 3: by Product

  • Kits and Reagents
  • Expression Vectors
  • Competent Cells
  • Plastic Consumables and Accessories

Segmentation 4: by Expression System

  • Mammalian Cell Expression System
  • Bacterial Cell Expression System
  • Insect Cell Expression System
  • Yeast Cell Expression System
  • Others

Segmentation 5: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe protein expression market has been segmented on the basis of various categories, such as application, end user, product, and expression system. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe protein expression market is a highly fragmented one, with many smaller and private companies constantly entering it. Key players in the protein expression market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Protein Expression Market Trend Analysis
    • 1.1.2 Continuous Innovations in Fields such as Automation of Protein Expression Processes
    • 1.1.3 Advancements in Protein Engineering and Design
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
  • 1.3 Regulatory Landscape
  • 1.4 Impact Analysis for Key Global Events - COVID-19
  • 1.5 Market Entry Barriers and Opportunities
    • 1.5.1 Pain Points for Manufacturers
    • 1.5.2 Opportunities for Manufacturers
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Increasing Demand for Protein Biologics Creating the Need for Protein Expression
      • 1.6.1.2 Increasing Biopharmaceutical R&D Influencing the Use of Protein Expression
      • 1.6.1.3 Increasing Protein Synthesis Funding
    • 1.6.2 Market Restraints
      • 1.6.2.1 Long and Complicated Regulatory Timelines and Approvals of Recombinant Proteins and Biologics
      • 1.6.2.2 Intricate and Fluctuating Nature of Protein Expression Necessitating a Demand for Highly Trained Personnel
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Advancements in Microfluidics Requiring the Use of Protein Expression
      • 1.6.3.2 Rising Awareness of Proteomics in Emerging Countries

2 Region

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 France
      • 2.3.6.1 Application
      • 2.3.6.2 Product
    • 2.3.7 Germany
      • 2.3.7.1 Application
      • 2.3.7.2 Product
    • 2.3.8 U.K.
      • 2.3.8.1 Application
      • 2.3.8.2 Product
    • 2.3.9 Spain
      • 2.3.9.1 Application
      • 2.3.9.2 Product
    • 2.3.10 Italy
      • 2.3.10.1 Application
      • 2.3.10.2 Product
    • 2.3.11 Rest-of-Europe
      • 2.3.11.1 Application
      • 2.3.11.2 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Company Assessment
  • 3.2 Market Ecosystem and Key Players
    • 3.2.1 Jena Bioscience
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View
    • 3.2.2 Lonza Bioscience
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Services/Service Portfolio
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Key Personnel
      • 3.2.2.5 Analyst View
    • 3.2.3 Merck KGaA
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products/Product/Service Portfolio
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Key Personnel
      • 3.2.3.5 Analyst View
    • 3.2.4 Oxford Expression Technologies Ltd
      • 3.2.4.1 Overview
      • 3.2.4.2 Top Products/Product Portfolio
      • 3.2.4.3 Top Competitors
      • 3.2.4.4 Key Personnel
      • 3.2.4.5 Analyst View
    • 3.2.5 QIAGEN N.V.
      • 3.2.5.1 Overview
      • 3.2.5.2 Top Products/Product Portfolio
      • 3.2.5.3 Top Competitors
      • 3.2.5.4 Key Personnel
      • 3.2.5.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Protein Expression Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 2: Europe Protein Expression Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Protein Expression Market (by Product), $Million, 2023 and 2033
  • Figure 4: Europe Protein Expression Market (by Expression System), $Million, 2023 and 2033
  • Figure 5: Key Events to Keep Track of within the Protein Expression Market
  • Figure 6: Advantages of Using Automation for Protein Expression
  • Figure 7: Supply Chain and Risks within the Supply Chain
  • Figure 8: Impact of COVID-19 on Protein Expression Market
  • Figure 9: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 10: Recently Launched Protein Biologics, their Indications, and Manufacturers
  • Figure 11: Total Pharmaceutical Research and Development Pipeline Size (by Year), 2010-2023
  • Figure 12: All Protein Synthesis Funding between 2022 and 2023
  • Figure 13: Timeline of Biologics Clinical Trials
  • Figure 14: Challenges at each of the Protein Expression Steps
  • Figure 15: Timeline of Microfluidics over the Years
  • Figure 16: Examples of Increasing Awareness with Respect to Proteomics in India and China
  • Figure 17: Number of Authorized Biologics in China Compared to the U.S. (2016-2020)
  • Figure 18: France Protein Expression Market, $Million, 2022-2033
  • Figure 19: Germany Protein Expression Market, $Million, 2022-2033
  • Figure 20: U.K. Protein Expression Market, $Million, 2022-2033
  • Figure 21: Spain Protein Expression Market, $Million, 2022-2033
  • Figure 22: Italy Protein Expression Market, $Million, 2022-2033
  • Figure 23: Rest-of-Europe Protein Expression Market, $Million, 2022-2033
  • Figure 24: Strategic Initiatives, 2021-2023
  • Figure 25: Share of Strategic Initiatives, 2021-2023
  • Figure 26: Data Triangulation
  • Figure 27: Top-Down and Bottom-Up Approach
  • Figure 28: Assumptions and Limitations

List of Tables

  • Table 1: Europe Protein Expression Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Recent Advancements in Protein Engineering
  • Table 4: Protein Expression Market, Product Benchmarking by Expression System
  • Table 5: Examples of Five Regulatory Bodies and Recombinant Protein
  • Table 6: Protein Expression (by Region), $Million, 2022-2033
  • Table 7: Europe Protein Expression Market (by Application), $Million, 2022-2033
  • Table 8: Europe Protein Expression Market (by End User), $Million, 2022-2033
  • Table 9: Europe Protein Expression Market (by Product), $Million, 2022-2033
  • Table 10: Europe Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 11: France Protein Expression Market (by Application), $Million, 2022-2033
  • Table 12: France Protein Expression Market (by End User), $Million, 2022-2033
  • Table 13: France Protein Expression Market (by Product), $Million, 2022-2033
  • Table 14: France Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 15: Germany Protein Expression Market (by Application), $Million, 2022-2033
  • Table 16: Germany Protein Expression Market (by End User), $Million, 2022-2033
  • Table 17: Germany Protein Expression Market (by Product), $Million, 2022-2033
  • Table 18: Germany Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 19: U.K. Protein Expression Market (by Application), $Million, 2022-2033
  • Table 20: U.K. Protein Expression Market (by End User), $Million, 2022-2033
  • Table 21: U.K. Protein Expression Market (by Product), $Million, 2022-2033
  • Table 22: U.K. Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 23: Spain Protein Expression Market (by Application), $Million, 2022-2033
  • Table 24: Spain Protein Expression Market (by End User), $Million, 2022-2033
  • Table 25: Spain Protein Expression Market (by Product), $Million, 2022-2033
  • Table 26: Spain Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 27: Italy Protein Expression Market (by Application), $Million, 2022-2033
  • Table 28: Italy Protein Expression Market (by End User), $Million, 2022-2033
  • Table 29: Italy Protein Expression Market (by Product), $Million, 2022-2033
  • Table 30: Italy Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 31: Rest-of-Europe Protein Expression Market (by Application), $Million, 2022-2033
  • Table 32: Rest-of-Europe Protein Expression Market (by End User), $Million, 2022-2033
  • Table 33: Rest-of-Europe Protein Expression Market (by Product), $Million, 2022-2033
  • Table 34: Rest-of-Europe Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 35: Market Share